HTA criteria adopted in different models of public healthcare systems for orphan drugs: A scoping review
Article in Health Policy (May 2024)
The most recent citing publications are shown below. View all 13 publications that cite this research output on Dimensions.
Innovative thinking of clinical investigation for rare disease drug development
Article in Orphanet Journal of Rare Diseases (September 2023)
Do Reimbursement Recommendations by the Canadian Agency for Drugs and Technology in Health Translate Into Coverage Decisions for Orphan Drugs in the Canadian Province of Ontario?
Article in Value in Health (March 2023)